Breaking News Instant updates and real-time market news.

LGF.A

Lionsgate

$9.36

-0.34 (-3.51%)

, LGF.B

Lionsgate

$8.71

-0.38 (-4.18%)

09:02
11/14/19
11/14
09:02
11/14/19
09:02

Lionsgate, Amazon.com enter UK output deal

Amazon (AMZN) announced that it has struck a new deal with Lionsgate (LGF.A, LGF.B) to be the UK's first window streaming home to the studio's recently released and upcoming theatrical feature films. The multi-year deal, which begins on 1st January 2020, will enable Prime members in the UK, or those subscribing to the monthly standalone Prime Video service offer, to access exciting, star-driven Lionsgate hits like Angel Has Fallen, Rambo: Last Blood and Lionsgate UK's The Personal History of David Copperfield. The agreement also encompasses eagerly-anticipated upcoming Lionsgate films such as the critically-acclaimed Knives Out, the action epic Midway and the buzzy Bombshell.

LGF.A

Lionsgate

$9.36

-0.34 (-3.51%)

LGF.B

Lionsgate

$8.71

-0.38 (-4.18%)

AMZN

Amazon.com

$1,753.84

-24.49 (-1.38%)

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

LGF.A Lionsgate
$9.36

-0.34 (-3.51%)

07/24/19
GSCO
07/24/19
UPGRADE
Target $19
GSCO
Buy
Goldman upgrades Lionsgate to Buy on 'compelling' risk/reward after selloff
Goldman Sachs analyst Drew Borst upgraded Lionsgate (LGF.A) to Buy from Neutral while lowering his price target for the shares to $19 from $24. The shares are down 24% since the company last reported results on May 23 due to concerns about forward growth, balance sheet leverage and competitive positioning, Borst tells investors in a research note. The analyst, however, finds the stock's risk/reward "compelling" at current valuation levels. He sees four potential catalysts to re-rate the multiple higher -- upward revisions to estimates, improving subscriber growth at for Starz International streaming, balance sheet de-levering, and "M&A optionality" given the growing scarcity of scaled content libraries and production assets.
08/19/19
IMPC
08/19/19
UPGRADE
Target $14
IMPC
Outperform
Lionsgate upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst David Miller upgraded Lionsgate to Outperform from In-Line and raised his price target on the shares to $14 from $13 citing the 27% pullback in the stock since the end of April and his view that the "worst case scenario" for a Starz-level equity raise is priced into the stock.
09/23/19
WELS
09/23/19
INITIATION
Target $15
WELS
Outperform
Lionsgate initiated with an Outperform at Wells Fargo
Wells Fargo analyst Steven Cahall initiated Lionsgate with an Outperform rating and $15 price target, stating that sentiment is "at an all-time low, but frankly, that's the opportunity." While he does not believe a buyer for Lionsgate or Starz will come in the near-term, he does view the company as "a very logical merger partner with other midsize studios," Cahall tells investors.
11/12/19
JPMS
11/12/19
NO CHANGE
Target $14
JPMS
Overweight
Lionsgate shares offer 'notable upside' potential, says JPMorgan
While there is no question the risk profile of Lionsgate is elevated, the stock offers an opportunity for "notable upside" given its "depressed" valuation and potential resolution of several overhangs, JPMorgan analyst Alexia Quadrani tells investors in a research note. She attributes the recent pressure on the shares to "several negative headlines," most recently on the news of the potential drop of Starz from Comcast's premium cable channel bundle. However, the analyst expects a renewal with Comcast will be a near-term catalyst to Lionsgate shares. She keeps an Overweight rating on the name with a $14 price target.
LGF.B Lionsgate
$8.71

-0.38 (-4.18%)

04/29/19
04/29/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lionsgate (LGF, LGF.A, LGF.B) downgraded to In-Line from Outperform at Imperial Capital with analyst David Miller citing additional promotional expenses related to the Starz international rollout. 2. Occidental Petroleum (OXY) downgraded to Hold from Buy at Jefferies with analyst Jason Gammel saying the company's hostile counter-offer for Anadarko (APC) is a "risky but perhaps necessary move against a better-capitalized bidder for a company that rejected its initial overtures." 3. CVS Health (CVS) downgraded to Neutral from Outperform at Credit Suisse with analyst A.J. Rice saying the stock faces a transitional year as it tries to drive seismic changes in healthcare. 4. Intel (INTC) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the company's Q1 earnings miss and reduced FY19 outlook that reflected the company's Data Center Group weakness, which he calls "the linchpin of growth." 5. 3M (MMM) downgraded to Hold from Buy at Gordon Haskett with analyst John Inch downgraded saying his concerns extend beyond the company's Q1 earnings miss and steep guidance reduction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/18/19
IMPC
06/18/19
NO CHANGE
Target $13
IMPC
In-Line
Lionsgate price target lowered to $13 from $16 at Imperial Capital
Imperial Capital analyst David Miller lowered his price target for Lionsgate Entertainment (LGF.B) to $13 from $16 and maintains an In-Line rating on the shares.
AMZN Amazon.com
$1,753.84

-24.49 (-1.38%)

11/06/19
DADA
11/06/19
NO CHANGE
Target $20
DADA
Buy
Sonos rallies after DA Davidson calls 'natural acquisition target' for Apple
DA Davidson analyst Tom Forte reiterates a Buy rating on Sonos (SONO) with a $20 price target following Alphabet's (GOOG, GOOGL) acquisition of Fitbit (FIT). The stock in early trading is up 82c to $14.28. The analyst sees Sonos as the most likely company he covers to have its shares rally from either an improvement in investor perception or a takeover. Sonos is the "best house" on the "bad block" of hardware companies, and is "adjacent to the mansion on the neighboring block, Apple (AAPL)," Forte tells investors in a research note. Similar to Apple, Sonos makes products that are superior to the competition, has an eye for design, and boasts a premium brand that enables it to sell its products at higher prices than others, the analyst says. Further, Forte believes that similar to Fitbit not getting proper credit for its healthcare-related efforts, Sonos does not get credit for its superior technology and premium brand. As such, he sees Sonos as a "natural acquisition target for Apple." Furthermore, while less obvious than Apple, Amazon (AMZN) could acquire Sonos to advance its connected home efforts, according to Forte. The analyst also thinks the company could go private given the "lack of appreciation by Wall Street."
11/05/19
RSBL
11/05/19
UPGRADE
Target $13
RSBL
Buy
Applied Optoelectronics upgraded to Buy ahead of guidance at Rosenblatt
As previously reported, Rosenblatt analyst Jun Zhang upgraded Applied Optoelectronics (AAOI) to Buy from Neutral with a price target of $13, up from $10. When the company reports Q3 results tomorrow, Zhang believes it will provide guidance for sequential revenue growth in Q4, powered by Microsoft's (MSFT) increasing demand for 100G products and demand from Amazon (AMZN) for 40G products. In addition to demand in the U.S. hyperscale market, Zhang sees Applied benefiting in 2020 from potential opportunities in 5G, a likely design wins at ZTE (ZTCOY), and potential opportunities to supply to Cisco (CSCO) clients.
10/28/19
COMP
10/28/19
NO CHANGE
COMP
Compass Point says Amazon could challenge Microsoft winning JEDI contract
Compass Point policy analyst Isaac Boltansky said, following the Department of Defense awarding the $10B JEDI contract to Microsoft (MSFT) over Amazon (AMZN), that his channel checks indicated Amazon could challenge the decision. However, he believes that while there will be "a degree of handwringing" about the political issues surrounding the contract, he feels "lawmakers are unlikely to wade too deeply into these waters given the increasing toxicity of the Big Tech conversation in Washington." Boltansky added that the JEDI contract win was a "significant victory for Microsoft," and that it could also yield some benefit for Oracle (ORCL), as it has a cloud interoperability arrangement with Microsoft.
11/13/19
NOMU
11/13/19
NO CHANGE
Target $42
NOMU
Neutral
Nike ending direct Amazon sales positive for Dick's, says Nomura Instinet
Nomura Instinet analyst Michael Baker says Nike's (NKE) decision to stop selling product directly to Amazon (AMZN), as reported this morning by Bloomberg, should be positive for Dick's Sporting Goods (DKS). Nike product will still be available on Amazon through its third-party market place, so the good for Dick's "is only modest," Baker tells investors in a research note titled "DKS Winning Online." The analyst believes Dick's is one of Nike's most valuable partners. The company accounts for about 6.6% of Nike's North American sales and 9.6% of its North American wholesale sales, and the penetration has been growing, contends Baker. This makes Dick's Nike's second-biggest wholesale partner, says the analyst, how keeps a Neutral rating on Dick's with a $42 price target.

TODAY'S FREE FLY STORIES

MGTA

Magenta Therapeutics

$12.99

-0.14 (-1.07%)

05:03
12/06/19
12/06
05:03
12/06/19
05:03
Initiation
Magenta Therapeutics initiated  »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

ODT

Odonate Therapeutics

$33.29

-1.75 (-4.99%)

05:02
12/06/19
12/06
05:02
12/06/19
05:02
Initiation
Odonate Therapeutics initiated  »

Odonate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNSA

Kiniksa

$10.01

-0.1 (-0.99%)

05:00
12/06/19
12/06
05:00
12/06/19
05:00
Upgrade
Kiniksa rating change  »

Kiniksa assumed to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMED

Amedisys

$165.41

-1.22 (-0.73%)

04:58
12/06/19
12/06
04:58
12/06/19
04:58
Initiation
Amedisys initiated  »

Amedisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$46.09

-0.49 (-1.05%)

04:56
12/06/19
12/06
04:56
12/06/19
04:56
Downgrade
Sanofi rating change  »

Sanofi downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

CDEV

Centennial Resource Development

$3.41

0.06 (1.79%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Downgrade
Centennial Resource Development rating change  »

Centennial Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$3.93

-0.135 (-3.32%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Downgrade
Encana rating change  »

Encana downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNS

Cadence Design

$65.77

-0.15 (-0.23%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Cadence Design management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SPGI

S&P Global

$271.33

2.81 (1.05%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
S&P Global management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Jan

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Wolfe Research healthcare analysts to hold an analyst/industry webcast »

Healthcare Analysts…

FTNT

Fortinet

$104.92

1.37 (1.32%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Fortinet management to meet with Oppenheimer »

Meetings with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

  • 08

    Jan

KMPR

Kemper

$73.65

-0.76 (-1.02%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Kemper management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 11

    Dec

  • 12

    Dec

EXTR

Extreme Networks

$6.80

-0.08 (-1.16%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Extreme Networks management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 10

    Dec

AXP

American Express

$118.31

0.32 (0.27%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
American Express management to meet with William Blair »

Group Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

OPRT

Oportun Financial

$20.13

0.11 (0.55%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Oportun Financial management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ILPT

Industrial Logistics Property Trust

$21.98

-0.515 (-2.29%)

, CBM

Cambrex

$59.99

(0.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Hot Stocks
Industrial Logistics Property to replace Cambrex in S&P 600 at open on 12/6 »

Permira Advisors is…

ILPT

Industrial Logistics Property Trust

$21.98

-0.515 (-2.29%)

CBM

Cambrex

$59.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNLO

Menlo Therapeutics

$4.20

0.2 (5.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Menlo Therapeutics management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MELI

MercadoLibre

$578.24

3.3 (0.57%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
MercadoLibre management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 17

    Dec

  • 17

    Dec

DSGX

Descartes Systems

$40.85

-1.59 (-3.75%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Descartes Systems management to meet with Wolfe Research »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MPWR

Monolithic Power

$162.23

0.24 (0.15%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Monolithic Power management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ENLAY

Enel

$0.00

(0.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Enel management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

WNC

Wabash

$15.51

0.17 (1.11%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Wabash management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Macquarie to hold a conference »

Asia Internet, Media and…

AZPN

Aspen Technology

$120.26

-0.95 (-0.78%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Recommendations
Aspen Technology analyst commentary  »

Aspen Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 12

    Dec

AAON

AAON

$49.14

0.78 (1.61%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
AAON management to meet with Sidoti »

Meetings with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.